Layer-by-layer interleukin-12 nanoparticles drive a safe and effective response in ovarian tumors.

BIOENGINEERING & TRANSLATIONAL MEDICINE(2023)

引用 4|浏览0
暂无评分
摘要
Ovarian cancer is especially deadly, challenging to treat, and has proven refractory to known immunotherapies. Cytokine therapy is an attractive strategy to drive a proinflammatory immune response in immunologically cold tumors such as many high grade ovarian cancers; however, this strategy has been limited in the past due to severe toxicity. We previously demonstrated the use of a layer-by-layer (LbL) nanoparticle (NP) delivery vehicle in subcutaneous flank tumors to reduce the toxicity of interleukin-12 (IL-12) therapy upon intratumoral injection. However, ovarian cancer cannot be treated by local injection as it presents as dispersed metastases. Herein, we demonstrate the use of systemically delivered LbL NPs using a cancer cell membrane-binding outer layer to effectively target and engage the adaptive immune system as a treatment in multiple orthotopic ovarian tumor models, including immunologically cold tumors. IL-12 therapy from systemically delivered LbL NPs shows reduced severe toxicity and maintained anti-tumor efficacy compared to carrier-free IL-12 or layer-free liposomal NPs leading to a 30% complete survival rate.
更多
查看译文
关键词
cancer immunotherapy,cytokine,drug delivery,layer‐by‐layer,nanomedicine,nanoparticle
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络